Pathway Capital competitors

Douglas Cifu is the Chief Executive Officer of Virtu Financial and was one of the co-founders of Virtu in 2008. Prior to joining Virtu, Mr. Cifu was a Partner at the international law firm Paul, Weiss, Rifkind, Wharton & Garrison (Paul Weiss). At Paul Weiss, Mr. Cifu served as a member of the Management Committee, Deputy Chair of the Corporate Department and co-head of the Private Equity Group.

An entrepreneurial executive specializing in growth strategies. Managing, motivating and coaching people toward a common business goal is a core strength. Experience includes Board of Directors, IPO, M&A, Sales, Business Development, Marketing and Operations. Expertise in start-ups to Fortune 6 environments.Applied growth strategies within the following market segments:In Vitro Diagnostics, Instrument Development, Single-Use bioreactors, Gene Expression Analysis, GMP services, Filtration, Cell Culture, Microscopy, Protein Crystallography, Liquid Chromatography, DNA/RNA chemistry, Peptide chemistry, Biologics, Biosimilars and Drug Development.

Larry Restieri is a Co-Head of the Personal Financial Management Group, CEO of Ayco at Goldman Sachs Ayco Personal Financial Management; Chief Executive Officer at The Ayco Co; and Partner at GOLDMAN SACHS GROUP INC and is based in New, York. He has worked as Associate at Finn Dixon & Herling LLP and Associate at Simpson Thacher & Bartlett LLP. Larry attended Harvard University between 1986 and 1990 and Fordham University School of Law between 1993 and 1996.